The interaction of gender and smoking on bladder cancer risks

Standard

The interaction of gender and smoking on bladder cancer risks. / Janisch, Florian; Shariat, Shahrokh F; Schernhammer, Eva; Rink, Michael; Fajkovic, Harun.

in: CURR OPIN UROL, Jahrgang 29, Nr. 3, 05.2019, S. 249-255.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ReviewForschung

Harvard

Janisch, F, Shariat, SF, Schernhammer, E, Rink, M & Fajkovic, H 2019, 'The interaction of gender and smoking on bladder cancer risks', CURR OPIN UROL, Jg. 29, Nr. 3, S. 249-255. https://doi.org/10.1097/MOU.0000000000000602

APA

Janisch, F., Shariat, S. F., Schernhammer, E., Rink, M., & Fajkovic, H. (2019). The interaction of gender and smoking on bladder cancer risks. CURR OPIN UROL, 29(3), 249-255. https://doi.org/10.1097/MOU.0000000000000602

Vancouver

Bibtex

@article{a5f84fb0a18542e8957ce137c449a99d,
title = "The interaction of gender and smoking on bladder cancer risks",
abstract = "PURPOSE OF REVIEW: Although smoking and gender are well-established bladder cancer (BCa) risk factors, a significant interaction with other risk factors could help in the identification of patterns for early detection and prevention strategies.RECENT FINDINGS: Smoking appears to be more strongly associated with BCa risk in women than in men, which could be related to differences in metabolism, smoking behavior, exposure patterns, and DNA repair mechanisms. BMI is associated with a higher risk of BCa with negligible difference between genders. The risk for BCa is increased in postmenopausal women, specifically in women with earlier menopausal age (<45 years). Other potential risk factors such as alcohol, arsenic exposure, and particulate matter inhalation seem to affect the genders differently.Female smokers experience a higher risk of disease recurrence after bacillus Calmette-Gu{\'e}rin therapy than their male counterparts. Lastly, smoking appears to negatively affect the outcome of radiotherapy in women, but not that of men.SUMMARY: Several lines of evidence point to an interaction between smoking and gender, whereas their impact on other potential risk factors remains to be elucidated. Identifying such differential effects could allow for gender-specific prevention, early detection, and treatment strategies.",
keywords = "BCG Vaccine/therapeutic use, Early Detection of Cancer, Female, Humans, Male, Neoplasm Recurrence, Local/etiology, Risk Factors, Sex Factors, Smoking/adverse effects, Urinary Bladder Neoplasms/diagnosis",
author = "Florian Janisch and Shariat, {Shahrokh F} and Eva Schernhammer and Michael Rink and Harun Fajkovic",
year = "2019",
month = may,
doi = "10.1097/MOU.0000000000000602",
language = "English",
volume = "29",
pages = "249--255",
journal = "CURR OPIN UROL",
issn = "0963-0643",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

RIS

TY - JOUR

T1 - The interaction of gender and smoking on bladder cancer risks

AU - Janisch, Florian

AU - Shariat, Shahrokh F

AU - Schernhammer, Eva

AU - Rink, Michael

AU - Fajkovic, Harun

PY - 2019/5

Y1 - 2019/5

N2 - PURPOSE OF REVIEW: Although smoking and gender are well-established bladder cancer (BCa) risk factors, a significant interaction with other risk factors could help in the identification of patterns for early detection and prevention strategies.RECENT FINDINGS: Smoking appears to be more strongly associated with BCa risk in women than in men, which could be related to differences in metabolism, smoking behavior, exposure patterns, and DNA repair mechanisms. BMI is associated with a higher risk of BCa with negligible difference between genders. The risk for BCa is increased in postmenopausal women, specifically in women with earlier menopausal age (<45 years). Other potential risk factors such as alcohol, arsenic exposure, and particulate matter inhalation seem to affect the genders differently.Female smokers experience a higher risk of disease recurrence after bacillus Calmette-Guérin therapy than their male counterparts. Lastly, smoking appears to negatively affect the outcome of radiotherapy in women, but not that of men.SUMMARY: Several lines of evidence point to an interaction between smoking and gender, whereas their impact on other potential risk factors remains to be elucidated. Identifying such differential effects could allow for gender-specific prevention, early detection, and treatment strategies.

AB - PURPOSE OF REVIEW: Although smoking and gender are well-established bladder cancer (BCa) risk factors, a significant interaction with other risk factors could help in the identification of patterns for early detection and prevention strategies.RECENT FINDINGS: Smoking appears to be more strongly associated with BCa risk in women than in men, which could be related to differences in metabolism, smoking behavior, exposure patterns, and DNA repair mechanisms. BMI is associated with a higher risk of BCa with negligible difference between genders. The risk for BCa is increased in postmenopausal women, specifically in women with earlier menopausal age (<45 years). Other potential risk factors such as alcohol, arsenic exposure, and particulate matter inhalation seem to affect the genders differently.Female smokers experience a higher risk of disease recurrence after bacillus Calmette-Guérin therapy than their male counterparts. Lastly, smoking appears to negatively affect the outcome of radiotherapy in women, but not that of men.SUMMARY: Several lines of evidence point to an interaction between smoking and gender, whereas their impact on other potential risk factors remains to be elucidated. Identifying such differential effects could allow for gender-specific prevention, early detection, and treatment strategies.

KW - BCG Vaccine/therapeutic use

KW - Early Detection of Cancer

KW - Female

KW - Humans

KW - Male

KW - Neoplasm Recurrence, Local/etiology

KW - Risk Factors

KW - Sex Factors

KW - Smoking/adverse effects

KW - Urinary Bladder Neoplasms/diagnosis

U2 - 10.1097/MOU.0000000000000602

DO - 10.1097/MOU.0000000000000602

M3 - SCORING: Review article

C2 - 30888973

VL - 29

SP - 249

EP - 255

JO - CURR OPIN UROL

JF - CURR OPIN UROL

SN - 0963-0643

IS - 3

ER -